GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 4.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,213 | -87.3% | 1,729 | -62.7% | 0.00% | – |
| Q1 2024 | $17,463 | +9.3% | 4,632 | -5.3% | 0.00% | – |
| Q4 2023 | $15,972 | +69.7% | 4,892 | +70.5% | 0.00% | – |
| Q3 2023 | $9,414 | -51.7% | 2,870 | -34.0% | 0.00% | -100.0% |
| Q2 2023 | $19,475 | +58915.2% | 4,347 | -36.5% | 0.00% | 0.0% |
| Q1 2023 | $33 | +43.5% | 6,844 | -4.3% | 0.00% | 0.0% |
| Q4 2022 | $23 | -99.9% | 7,152 | +35.9% | 0.00% | – |
| Q3 2022 | $17,000 | +466.7% | 5,261 | +634.8% | 0.00% | – |
| Q2 2022 | $3,000 | +50.0% | 716 | +20.7% | 0.00% | – |
| Q1 2022 | $2,000 | -71.4% | 593 | -49.3% | 0.00% | – |
| Q4 2021 | $7,000 | +75.0% | 1,170 | +110.8% | 0.00% | – |
| Q3 2021 | $4,000 | – | 555 | +670.8% | 0.00% | – |
| Q2 2021 | $0 | – | 72 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timelo Investment Management Inc. | 605,288 | $774,769 | 0.44% |
| Cable Car Capital LLC | 145,000 | $185,600 | 0.20% |
| CM Management, LLC | 90,000 | $115,200 | 0.11% |
| HOHIMER WEALTH MANAGEMENT, LLC | 330,000 | $422,400 | 0.10% |
| DME Capital Management, LP | 566,130 | $724,646 | 0.04% |
| Warberg Asset Management LLC | 51,600 | $65,532 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 35,820 | $45,850 | 0.00% |
| Alyeska Investment Group, L.P. | 450,000 | $576,000 | 0.00% |
| Gilbert & Cook, Inc. | 10,000 | $12,800 | 0.00% |
| Virtu Financial LLC | 27,356 | $35 | 0.00% |